Expanding Precision Oncology

With precision medicine, doctors tailor treatment to the molecular features of a person’s cancer. MSK scientists have identified hundreds of cancer-related mutations, proteins, and other traits, and pioneered new targeted therapies that take aim at them.

Support precision medicine programs
Three MSK experts standing in a lab, facing the camera and smiling

Pinpointing molecular drivers of cancer today

To develop targeted drugs that give patients more tomorrows

The discovery of molecular drivers of cancer has revolutionized targeted therapies, which are changing, enhancing, and extending lives around the world. MSK laid the foundation for a future in which profound molecular insights can lead to powerful new therapies and the next generation of precision medicine tools. 

See how your gift can propel precision oncology

Support lab-to-clinic research
Support lab-to-clinic research

Through a transformative $100 million gift, longtime donors Fiona and Stanley Druckenmiller are supporting promising translational research at MSK through the Fiona and Stanley Druckenmiller Presidential Innovation Fund.

Learn what donors can do

Help us make the next big leap in precision oncology

Make a gift
Donate to MSK to fund life-changing research and care.
Start a fundraiser
Invite your friends and family to join you in your mission
Attend an event
Come to a fundraising event to show your support.
To discover more ways to partner in our work, email us.
Contact us
Two children sit outside, leaning toward each other playfully
Leading science.   Changing lives.   The MSK Campaign.

The MSK community is raising essential funds to accelerate advances in the most promising areas of cancer research and care, like precision oncology. 

Learn about The MSK Campaign